Ontvang nu dagelijks onze kooptips!

word abonnee
Van beleggers
voor beleggers
desktop iconMarkt Monitor

Franse aandelen« Terug naar discussie overzicht

Abivax

527 Posts
Pagina: «« 1 ... 22 23 24 25 26 27 | Laatste | Omlaag ↓
  1. Ponzi_NL 14 februari 2025 12:37
    ABTECT Phase 3 Update

    Enrollment Progress: 1,003 of the targeted 1,224 participants enrolled to date.

    Top-Line Results: Induction trial results expected in Q3 2025, with 44-week maintenance data to follow in Q2 2026.

    Regulatory Pathway: NDA submission planned for H2 2026, assuming positive clinical data.

    Participant Characteristics: Blinded baseline data aligns with the target population defined during Phase 2b.

    Safety Profile: No new safety signals observed to date with the oversight of the independent Data Monitoring Committee.
527 Posts
Pagina: «« 1 ... 22 23 24 25 26 27 | Laatste |Omhoog ↑

Meedoen aan de discussie?

Word nu gratis lid of log in met je emailadres en wachtwoord.